Aspergillus fumigatus is a model fungal pathogen and a common cause of severe infections and diseases. CD8 + T cells are present in the human and murine T cell repertoire to the fungus.
Introduction
Toll-like receptor 3 (TLR3) plays a key role in modulating inflammation and innate immunity in the airway. Although best known for recognition of viral double stranded RNA (dsRNA) and its synthetic analog polyinosinic:polycytidylic acid [poly(I:C)], 1 TLR3 also recognizes endogenous ligands 2 including heterologous RNA released from or associated with necrotic cells or generated by in vitro transcription. 3 Thus, TLR3, together with other intracellular signaling proteins, 4 induces or otherwise modulates innate immune responses and inflammation in settings that are not associated with viral dsRNA. TLR3 signaling may also modulate adaptive immune responses by providing cross-priming of cytotoxic T lymphocytes through signaling in DCs [5] [6] via type I IFNs 7 and in the absence of CD4 + T cell help. 8 Thus, it is not surprising that individuals with mutations in key TLR3 signaling components have a selective immunodeficiency manifested by recurrent episodes of Herpes simplex virus 1 encephalitis 9-10 or enteroviral myocarditis/cardiomyopathy.
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Aspergillus fumigatus is a model fungal pathogen and a common cause of severe infections and diseases. Humans inhale hundreds of conidia everyday without adverse consequences, 12 except for a minority of persons in whom defense systems fail and a lifethreatening form of disease can develop. CD4 + and CD8 + T cells are present in the human T cell repertoire to the fungus [13] [14] [15] and adoptive transfer of A. fumigatus-specific CD4 + T cells conferred protection against invasive fungal infection. [15] [16] Recent studies indicate a role for TLR3 in murine aspergillosis. By functioning as an endogenous sensor of fungal RNA, 17 TLR3
mediates expression of the enzyme indoleamine 2,3-dioxygenase (IDO) on both epithelial 18 and DCs, 19 contributing to the local regulation of innate and adaptive inflammation to the fungus.
However, the findings that protective memory CD8 + T cells are induced against fungi [20] [21] [22] [23] suggest a possible role for TLR3 in activating memory CD8 + T cell-mediated immunity to the fungus.
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We evaluated the contribution of TLR3 to the activation of CD8 + T cells to A. fumigatus in preclinical models of aspergillosis and in hematopoietic stem cell transplanted (HSCT) patients with a single nucleotide polymorphism (SNP) in TLR3. We found that TLR3 on murine and human DCs sorts fungal RNA for activation of class I-restricted protective memory CD8 + T cell responses to the fungus. TLR3 deficiency was associated with severe infection in mice and a TLR3 SNP resulting in a loss-of-function phenotype of DCs was associated with increased susceptibility to aspergillosis and concomitant failure to activate antifungal CD8 + T cells in HSCT patients.
Materials and methods

Mice
Female C57BL/6 mice (Charles River, Calco, Italy) and homozygous Tlr3 -/-mice on the C57BL/6 background were bred under pathogen-free conditions in the Animal Facility of the University of Perugia, Perugia, Italy and experiments were performed according to the Italian Approved Animal
Welfare Assurance A-3143-01.
Fungal and bacterial strains, infections and treatments
Viable resting and swollen conidia from the A. fumigatus Af293 strain were obtained as described. 19 A GFP-expressing strain of A. fumigatus (provided by M.M. Moore, Department of Biological Sciences, Simon Fraser University, Burnaby, British Columbia, Canada) was used to track viable fungi. Infection and bronchoalveolar lavage (BAL) morphometry (at least 200 cells per cytospin preparation were counted) were performed as described. 19 Mice were monitored for fungal growth (CFU/organ, mean ± SE), histopathology [periodic acid-Schiff (PAS) and Gomori's methenamine silver staining of lung tissue sections] and lung immunofluorescence (see below). Histology sections and cytospin preparations were observed using a BX51 microscope (Olympus, Milan, Italy) and images were captured using a high-resolution DP71 camera (Olympus). Poly(I:C) (Sigma-Aldrich, St. Louis, MO) was given (50 µg) twice i.p. the day of and a day after infection.
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Control mice received PBS. Mice were treated with 300 µg of anti-CD4 (GK 1.5) or anti-CD8
(YTS 169) mAbs (provided by L. Boon, Bioceros BV, Netherlands) the day before and one and three days after infection. Control mice received isotype control rat IgG2a mAb (eBR2a) (eBioscience, San Diego, CA). Depletion of the corresponding T cell subsets with this regimen was monitored in each experiment and was consistently between 95 to 98%, lasting for at least 3 days after treatment (data not shown). Mice were infected i.n. with the Pseudomonas aeruginosa PAO1
(ATCC BAA-47) strain. Bacterial CFU/organ (mean ± SE) were quantified by plating lung homogenates on trypticase soy agar plates.
Vaccination models
Two vaccination models were used, one using live A. fumigatus conidia or purified fungal antigens given with murine CpG oligodeoxynucleotide 1862, the other using fungus-pulsed DCs. 24 
Fluorescence microscopy and morphometric analysis
Mice were perfused with 2 ml of cold PBS and 1:1 OCT (Cryomount Histolab, Gothenburg, Sweden). The lung was snap frozen in OCT and 5-µm sections were performed with a semiautomatic cryostat (MC4000; Histo-Line Laboratories, Milan, Italy). Rehydrated sections were fixed in 4% paraformaldehyde, blocked with 5% BSA and stained with a combination of Alexa
Fluor 488 anti-mouse CD11c (N418, BioLegend, Campoverde Srl, Milan, Italy) and anti-mouse CD3 (17A2, BioLegend) mAbs at room temperature for 1h. 4'-6-Diamino-2-phenylindole (DAPI, Molecular Probes, Invitrogen, Milan, Italy) was used to counterstain tissues and to detect nuclei.
Images were acquired using a fluorescence microscope (BX51 Olympus) with a 40× objective and the analySIS image processing software (Olympus).
Generation of bone marrow chimeras
Bone marrow chimeras were generated as described 18 (detailed in the Supplemental Materials).
Cell preparation and cultures
Murine lung cells were isolated as described 24 (detailed in the Supplemental Materials). CD4 + or CD8 + T cells were isolated after incubation with FITC-labeled anti-CD4 or anti-CD8, followed by anti-FITC MicroBeads (Miltenyi Biotec, Bergisch Gladbach, Germany) and DCs were isolated with MicroBeads (Miltenyi Biotec) conjugated to hamster anti-mouse CD11c mAbs (N418) before magnetic cell sorting. 24 Upon written informed consent, human PBMCs were isolated using (Sigma-Aldrich) (2.5 µg/ml) was added after 2 h of pulsing to prevent fungal overgrowth.
Flow cytometry
Directly conjugated Abs were purchased from BD Pharmingen (San Diego, CA) (see Supplemental Materials for details). Cells were analyzed with a FACScan flow cytofluorometer (Becton Dickinson, San Jose, CA) equipped with CellQuest TM software.
Uptake tracking of GFP-expressing A. fumigatus in vivo
Single cell suspensions were prepared from lungs or draining lymph nodes depleted of T and B cells. Cells were immunostained with the CD11c markers and analyzed by flow cytometry. For the phagocytosis assay, see Supplemental Materials.
Antigen presentation in vitro, cytotoxic and conidiocidal assays
A panel of Ag presentation inhibitors (all from Sigma-Aldrich) at their optimum concentrations was added to DCs for 120 min prior to the 2 h pulsing with A. fumigatus conidia or RNA + DOTAP. We used 5 µg/ml chloroquine, 100 nM bafilomycin A, 5 µg/ml brefeldin A and 50 µM lactacystin.
After pulsing, DCs were fixed in 0.4% paraformaldehyde (Sigma-Aldrich) and extensively washed. 
Proliferative activity of human T lymphocyte clones
Limiting dilution and proliferation assays were performed as described 15 (detailed in the Supplemental Materials).
Western blotting
Blots of cell lysates were incubated with rabbit polyclonal Abs recognizing phospho-IRF3 (Ser396, 4D4G) followed by horseradish peroxidase-conjugated anti-mouse or anti-rabbit IgG, as per the manufacturer's instruction (Cell Signaling Technology, Danvers, MA). Immunoblotting for IDO was performed with rabbit polyclonal IDO-specific antibody on total lung cells. 18 Scanning densitometry was done on a Scion Image apparatus. The pixel density of bands was normalized against total protein or β-tubulin.
ELISA and real-time PCR
The level of cytokines in culture supernatants of DCs was determined by Kit ELISA (R&D Systems, Milan, Italy) at 24 h. The detection limits of the assays were <10 pg/ml for IL-12p70, <3
pg/ml for IL-10, <30 pg/ml for IL-23, <10 pg/ml for IL-17A and <10 pg/ml for IFN-γ. Cell lysis, RNA extraction and real-time PCR were performed as described. [18] [19] Table S1 . Grafts consisted of immunoselected CD34 + peripheral blood cells in all cases and transplantation procedures, antifungal prophylaxis and surveillance for fungal infection were performed as described 27 (for details, see Supplemental Materials). Probable/proven fungal infection was defined according to the revised standard criteria from the European Organization for
Research and Treatment of Cancer/Mycology Study Group. Study approval was provided by the local ethics committee and informed written consent was obtained from all participants in accordance with the Declaration of Helsinki.
SNP genotyping
SNPs were selected from a literature review and public databases based on three selection criteria:
i) published evidence of association with human diseases, ii) localization to the promoter, untranslated or coding regions, and (iii) minor allele frequencies higher than 5% in the Caucasian population. Two TLR3 SNPs complied with the selection criteria: +1234C/T (L412F, rs3775291) and +95C/A (rs3775296). Genotyping was performed as described 27 (for details and primer sequences, see Supplemental Materials).
Statistical analysis
Student 
Results
Tlr3 -/-mice are highly susceptible to pulmonary aspergillosis
We evaluated resistance to primary pulmonary aspergillosis and reinfection in Tlr3 -/-and C57BL/6 mice. In the primary infection, fungal growth was higher in the lungs of Tlr3 -/-than control mice throughout the course of the infection ( Figure 1A ) and was associated with higher and persistent neutrophil recruitment and infiltration in the lung parenchyma and BAL fluids (inset of Figure 1B also showing numerous hyphae) and presence of peribronchiolar lymphocyte infiltrations (arrows in Figure 1B and immunofluorescence staining). Fungal dissemination was also observed in the brain of Tlr3 -/-mice ( Figure 1A ), more than 85% of which survived the infection (data not shown), if not immunosuppressed ( Figure 2C ). Stimulating TLR3 with the poly(I:C) agonist significantly reduced both the fungal growth and inflammation in the lungs of C57BL/6 mice (Supplemental Figure 1A -B), a finding further supporting that TLR3 provides protection in infection. Gene expression analysis of the lung confirmed the higher and more persistent inflammatory response in Tlr3 -/-than control mice, as revealed by the higher mRNA expression of Cxcl1, Cxcl2 and Mpo genes as well as of genes for inflammatory cytokines, such as Il1b ( Figure 1C ). The levels of Ifna1 and Ifnb1 were instead lower in Tlr3 -/-mice ( Figure 1C ). In addition, the conidiocidal activity of lung cells was half reduced in Tlr3 -/-mice compared to the C57BL/6 control (data not shown). Thus, TLR3 contributes to the effector activity of lung cells as well as to protection from unintended inflammation.
Because A. fumigatus is sensed by TLR3 on both epithelial 17 and DCs, 19 we determined the relative contribution of either type of cells to the TLR3-mediated protection by infecting chimeric mice with TLR3-deficient hematopoietic or nonhematopoietic cells. TLR3 deficiency in myeloid, more than epithelial cells, greatly impaired resistance to the fungus, as revealed by the inability to control fungal growth and restrict inflammation (Supplemental Figure 2) . Accordingly, DC cytokines were altered in Tlr3 -/-mice, in that levels of IL-12p70 were lower and those of IL-23
higher than in C57BL/6 mice (Supplemental Figure 3) . Thus, the myeloid-DC compartment is dysfunctional in Tlr3 -/-mice and this would predict altered T cell priming in infection.
CD8 + T cells do not expand in Tlr3 -/-mice upon infection
We evaluated the priming of CD4 + or CD8 + T cells in Tlr3 -/-or C57BL/6 mice by assessing the expansion of either T cell subset in infection. Both subsets expanded in the lung and the draining lymph nodes of infected C57BL/6 mice, whereas CD4 + but not CD8 + T cells expanded in the lung and less in the lymph nodes of Tlr3 -/-mice (Supplemental Figure 4) . Not only were CD8 + T cells defective, but CD4 + T helper (Th) cell subsets were also abnormally activated in Tlr3 -/-mice, as judged by the decreased expression of Tbet/Foxp3 specific transcripts in cells from draining lymph nodes ( Figure 1D ) and the production of IFN-γ/IL-10 in the lung ( Figure 1E ) and the increased expression of the Rorc transcript ( Figure 1D ) and the corresponding cytokine IL-17A ( Figure 1E ).
Thus, besides being required for the expansion of CD8 + T cells, TLR3 is also required for the proper CD4 + Th balance in infection. We know that the activation of IDO via the TLR3/TRIF pathway confers tolerogenic and Th1-activating potential to lung DCs in murine aspergillosis. [18] [19] Consistently, the enzyme was not induced in infection in the lung of Tlr3 -/-mice, despite being expressed at the basal level (Supplemental Figure 5) Figure 2C ), restrict the fungal growth ( Figure 2D ) and produce protective IFN-γ and IL-10 ( Figure   2E) . Surprisingly, however, they developed full resistance upon Crf1p vaccination ( Figure 2C -E).
The ability of TLR3 signaling to provide cross-priming of CD8 + T cells 5 Figure 3C ), as reported.
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As CCR7, known to be crucially required for CD8 + T cell priming in the lymph nodes, 31 is up-regulated in DCs upon conidia internalization, 32 we have assessed phagocytosis and Ccr7 expression in Tlr3 -/-DCs. We found that, while the phagocytosis percentage was not different (data not shown), the ability to internalize more than one conidia was greatly impaired in Tlr3 -/-DCs, as revealed by the decreased phagocytic index compared to DCs from C57BL/6 mice ( Figure 3D ).
Tlr3
-/-DCs also failed to up-regulate Ccr7 expression upon phagocytosis in a manner similar to control DCs upon blocking phagocytosis ( Figure 3E ). Thus, TLR3 contributes to Ccr7 expression of lung DCs upon conidia phagocytosis, likely conditioning their migratory capacity and priming efficiency. Figure 4A ). Fungal RNA also potently activated gene expression of type I IFNs ( Figure 4B ) and induced DC maturation ( Figure 4C ) in a TLR3-dependent manner. Although conidia similarly activated DCs, the residual activity observed in Tlr3 -/-DCs suggests the participation of other TLRs and/or intracellular RNA sensors in response to conidia. This was confirmed by the ability of conidia-pulsed DCs to prime CD4 + T cells in both C57BL/6 ( Figure 4D and E) and Tlr3 -/-mice ( Figure 4F and G) and, similar to RNA-pulsed DCs, to activate CD8 + T cells. Indeed, conidiapulsed DCs primed both T cell subsets from C57BL/6 mice for proliferation ( Figure 4D ) and Ifng expression ( Figure 4E ) and primed CD8 + T cells for Prf1 gene expression ( Figure 4E ). In contrast, RNA-pulsed DCs primed only CD8 + T cells for proliferation ( Figure 4D ), Ifng and Prf1 gene expression ( Figure 4E ), as well as for cytolytic activity against fungus-pulsed DCs ( Figure 4H ) or against the fungus itself ( Figure 4I ). Of interest, CD8 + T cell priming by RNA-pulsed DCs was abrogated in the presence of known inhibitors of the TLR3-dependent antigen presentation pathway 11 -bafilomycin A1 and chloroquine -and of the cytosolic, class I-dependent antigen presentation pathway 35 -brefeldin A and lactacystin -( Figure 4J ). These findings indicate that both the endosomal/lysosomal and proteasomal degradation pathways are involved in antigen processing after RNA transfection. Finally, fungus-or RNA-pulsed DCs isolated from Tlr3 -/-mice failed to confer protection upon adoptive transfer in vivo in C57BL/6 mice. However, fungus-or RNApulsed DCs from C57BL/6 mice also failed to confer protection upon transfer in Tlr3 -/-mice ( Figure 4K ), a finding suggesting that host DCs cross-present fungal antigens from migratory donor DCs, as proposed.
Recognition of fungal RNA is defective in
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A TLR3 SNP associates with increased risk of invasive aspergillosis in HSCT recipients
Given the above results, we investigated whether genetic variants affecting the function of TLR3 might influence susceptibility to aspergillosis in patients with predisposing conditions. To this purpose, we performed a genetic analysis of selected SNPs in TLR3 in a cohort of 223 consecutive HSCT recipients and respective donors (Table S1 ). Figure 5A ). Thus, recapitulating the murine findings, the specific contribution of the TLR3 +95C/A SNP to the infection appears to rely on its presence on myeloid cells. Moreover, the genetic association remained significant after correction for clinical co-variables, namely transplant matching, graft-versus-host disease (GVHD) and antifungal prophylaxis. Figure 8) , as described. 38 We found that TLR3 mRNA expression in WT BDCA-3 + cells was strongly induced following pulsing with each stimulus ( Figure 6A ). In contrast, BDCA-3 + cells bearing the +95C/A SNP displayed instead a marked decrease in TLR3 expression and responsiveness, a defect found to be genotype dose-dependent. We also found that expression of both IFNA1 and IFNB1 genes was triggered by all the stimuli in WT BDCA-3 + DCs, but not in TLR3 polymorphic cells ( Figure 6B ).
Finally, on assessing the ability of BDCA-3 + DCs to prime CD4 + or CD8 + T cells for proliferation,
we found that antigen-specific ( Figure 6C ) and, to a lesser extent, polyclonal ( Figure 6D Both CD4 + T cells [13] [14] [15] and CD8 + T cells 13, 25, 41 are present in the murine and human T cell repertoire to the fungus. However, the role of CD8 + T cells in infection, the specific fungal antigens they recognize and mechanisms underlying their activation are unknown. Our study provides evidence that both CD4 + and CD8 + T cells mediate memory responses to the fungus, contingent upon the nature of the fungal vaccine. Indeed, the cell wall glucanase Crf1p, known to be presented by three common human MHC class II alleles and to induce memory CD4 + Th1 cells to the fungus, 42 activated antifungal memory CD4 + Th1 cells independently of TLR3. We have evidence that recognition of Crf1p and CD4 + Th1 cell activation occur via MyD88 (unpublished observation), a finding suggesting that TLRs, other than TLR3, are involved in fungal antigen sampling and signaling for activation of the CD4 arm of the memory immune response to the fungus. However, the finding that Tlr3 -/-mice failed to mount an efficient memory response to the fungus, while retaining the ability to activate memory fungal-antigen specific CD4 + T cell responses, points to either a superior activity of the CD8-dependent mechanisms in immune memory to the fungus or a dysfunctional fungal processing in conditions of TLR3 deficiency.
TLR3 is a crucial "danger" signaling receptor that senses endogenous mRNA released by necrotic cells. 3 Thus, it is possible that TLR3 is activated in infection by sensing host damage.
However, in this case, CD8α + DCs are the solely responsible for cross-presenting antigens from apoptotic host cells. 43 In addition, we have recently shown that TLR3 restrained rather than promoted danger-dependent inflammation in aspergillosis. 17 Thus, sensing fungal RNA is the likely 18 function of TLR3 in infection. By migrating from early endosomes to LAMP1 + endosomes upon stimulation with dsRNA, TLR3 mediates the activation of DCs for the cross-presentation of exogenous antigens to CD8 + T cells. 6 Thus, TLR3-specific adjuvants are used to tailor CD8 + T cell immune responses independently of CD4 help. 44 We have tested the adjuvant activity of TLR3 and found that administration of Crf1p with poly(I:C) skewed T cell memory from class II-dependent CD4 + T cells -obtained with CpG known to block cross-presentation 43 -to class I-dependent CD8 + T cells (data not shown). This finding highlights the importance of adjuvants in skewing antifungal memory responses to candidate subunit fungal vaccines. However, the function of fungal RNA may go beyond its adjuvant activity as RNA-transfected DCs also originate fungal antigens. 26 As in viral infection, 45 fumigatus priming that was reported to be mediated by migratory CCR2 + inflammatory monocytes. 47 However, the role of TLR3 may go beyond regulation of adaptive memory to include regulation of inflammation and tolerance. The defective IDO activation likely contributed to the inability of these mice to promote tolerogenic responses to the fungus that are required to limit inflammation in infection. 18 Indeed, IL-17A-producing Th17 cells were expanded in Tlr3 -/-mice and likely contributed to inflammatory pathology, as suggested. 33 Besides the ability of type I IFNs to inhibit Th17 development, 48 it is interesting that, disabling lymph node priming, as in CCR7 deficiency, 49 promoted IL-17A-mediated lung pathology via abnormal T cell sensitization in ectopic lymph node formation. 50 Both defective Ccr7 expression and peribronchiolar lymphoid tissues were observed in Tlr3 -/-mice.
In conclusion, this study discloses the contribution of TLR3 to CD8 + T cell memory responses to A. fumigatus and identifies a TLR3 SNP leading to a loss-of-function phenotype of
DCs that is associated with susceptibility to infection and concomitant failure to activate antifungal CD8 + T cells in HSCT patients. Our findings may offer a plausible explanation for the increased susceptibility to aspergillosis after CMV reactivation in HSCT patients and predict that, in addition to TLR9, 51 TLR3 SNPs are also a likely risk factor for infection by CMV that, incidentally, shares with other members of the Herpes virus family, the ability to subvert endogenous MHC class I pathway via TRIF degradation. 52 Regardless of possible differences between viral and fungal crosspresentation pathways, our findings suggest that a defective antigen cross-presentation pathway may predispose to both viral and fungal infections in HSCT patients and point to novel therapeutic interventions.
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Figure legends 
